Filters
SPC granting conditions under the recast SPC Regulation
EUIPO invalidity decisions
Clarification of obligation to state reasons in trademark law cases (European General Court, May 24, 2023, T-477/21, Glaxo Group/EUIPO - Cipla Europe)
EU pharmaceutical package: What will change in pharmaceutical advertising?
.png?as=0&dmc=0&iar=0&thn=0&udi=0?as=0&h=182&iar=0&w=375&crop=1&hash=36C9E92F4DD615D12A75F909CE670E43)
What will the UPC cost me?
The revision of EU-“Bolar Exemption“ under the draft EU Pharmaceutical Package
Harmonization requirements due to the current “Bolar Exemption”-rule under EU law
The reform of marketing authorization procedures for medicinal products in the European Union
10 pitfalls in German employment litigation
An overview of the European Commission’s proposals for a Regulation on a unitary SPC and the recast of the SPC Regulation
